Many novel behavioral therapies for psychosis and schizophrenia are not available in the U.S., said Nev Jones, a Pitt social work professor who has advocated for integrating lived experience into psychosis research. Jones said this has left clinicians with few good options for treating this symptom. Read more in STAT.